Equities

Laurus Labs Ltd

LAURUSLABS:NSI

Laurus Labs Ltd

Actions
Health CarePharmaceuticals and Biotechnology
  • Price (INR)512.60
  • Today's Change23.10 / 4.72%
  • Shares traded4.51m
  • 1 Year change+37.22%
  • Beta1.4480
Data delayed at least 15 minutes, as of Nov 22 2024 10:29 GMT.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Profile data is unavailable for this security.

About the company

Laurus Labs Limited is an India-based pharmaceutical and biotechnology company. The Company offers integrated portfolio of Active Pharma Ingredients (API) including intermediates, Generic Finished dosage forms (FDF) and Contract Research services to cater to the needs of the global pharmaceutical industry. It operates through four divisions: Generics API, Generics FDF, Laurus Synthesis, and Laurus Bio. The Generics API is a third-party API supplier for antiretrovirals. The Generic FDF business focuses on oral solid formulations. The Laurus Synthesis provides drug development and manufacturing services to global pharma, crop science, animal health, and others. The Laurus Bio offers comprehensive services from clone and strain engineering to production, supporting clients across the microbial precision fermentation spectrum. The Company operates through two geographical segments: Revenue from customers within India-Domestic, and Revenue from customers outside India-Exports.

  • Revenue in INR (TTM)50.53bn
  • Net income in INR1.31bn
  • Incorporated2005
  • Employees6.01k
  • Location
    Laurus Labs LtdSerene Chambers, Road No 7, BanjarahillsHYDERABAD 500034IndiaIND
  • Phone+91 4 039804333
  • Fax+91 4 066594320
  • Websitehttp://www.lauruslabs.com/
More ▼

Peer analysis

Key Information
CompanyRevenue (TTM)Net income (TTM)Market capEmployeesPrice/earnings (TTM)Price/book value (MRQ)Price/cash flow (TTM)Price/sales (TTM)EPS (excl. extraordinary items, TTM)EPS (incl. extraordinary items, TTM)Revenue per share (TTM)Book value per share (MRQ)Asset turnover (TTM)Inventory turnover (TTM)Receivables turnover (TTM)Revenues per employee (TTM)Return on avg assets (TTM)Return on avg assets (5 yr avg)Return on investment (TTM)Return on investment (5 yr avg)Gross margin (TTM)Gross margin
(5 yr avg)
Net profit margin (TTM)Net Profit margin
(5 yr avg)
Quick ratio (MRQ)Interest coverage (TTM)Total debt to capital (MRQ)Payout ratio
(5 yr avg)
Revenue
(YOY change %)
Revenue
(5 yr growth rate)
Net income
(YOY change %)
Net income
(5 yr growth rate)
Capital expenditure
(5 yr growth rate)
Dividend
(5 yr growth rate)
Astrazeneca Pharma India Ltd14.85bn819.20m157.64bn940.00192.4523.20153.6210.6232.7632.76593.93271.741.272.5210.6315,792,680.006.9911.7811.4419.6244.8854.645.5210.271.44134.820.024625.6229.1712.2162.6624.29-10.46--
Jubilant Pharmova Ltd69.20bn5.93bn179.04bn995.0030.243.0118.522.5937.3837.38436.41375.040.59341.758.1569,544,720.005.052.966.013.5568.5068.478.515.131.202.510.34224.736.70-5.95226.43-33.086.482.13
Eris Lifesciences Ltd24.98bn3.48bn186.04bn3.08k53.456.7129.877.4525.5725.57183.35203.740.45852.905.968,110,753.006.7313.428.3916.8077.0379.9814.6924.960.85993.410.4626--19.2315.392.576.1527.72--
Neuland Laboratories Ltd.15.28bn2.80bn189.47bn1.65k67.7513.6555.1412.40217.98217.981,191.201,081.520.8472.144.859,273,565.0015.509.2520.0312.7152.1447.8118.3011.991.4031.560.07287.1330.8418.5183.5178.7617.8863.45
Wockhardt Ltd29.49bn-2.88bn190.86bn2.39k--5.31--6.47-19.85-19.85201.29221.320.3931.874.1912,318,300.00-3.93-4.56-6.33-8.2959.1055.26-10.00-12.700.56770.2470.3869--5.55-4.7317.17---4.71--
Alembic Pharmaceuticals Ltd63.57bn6.47bn204.00bn14.86k31.564.1722.063.2132.8832.88323.14248.680.9290.93665.434,278,678.009.4510.7213.3214.2573.8465.9810.1712.470.805712.620.179128.2910.199.6280.071.05-15.5914.87
Concord Biotech Ltd10.86bn3.28bn208.31bn1.38k53.7613.1054.5819.1937.0437.04114.79152.020.6551.113.557,884,886.0019.78--21.82--76.00--30.20--4.83194.730.0022--19.20--28.33------
Pfizer Ltd22.38bn6.18bn234.75bn1.72k37.996.2634.5810.49135.06135.06489.19819.900.52881.8311.1613,004,360.0014.6014.2217.0517.7165.0061.3727.6124.054.3046.210.026782.67-9.551.05-11.645.1433.359.24
Emcure Pharmaceuticals Ltd72.56bn5.67bn242.76bn11.15k42.275.8925.283.3530.3730.37389.63217.790.9781.803.966,510,068.008.027.1413.5513.9361.1159.298.207.810.95495.250.21650.0011.237.14-6.3621.35-5.93--
Natco Pharma Ltd.45.61bn19.45bn246.23bn4.02k12.663.4411.545.40108.58108.58254.65399.190.62910.89283.5711,356,080.0026.8212.3330.8514.2585.4773.0542.6325.164.19108.700.028318.9647.7213.8194.0916.59-4.7114.87
Laurus Labs Ltd50.53bn1.31bn263.73bn6.01k201.066.3848.375.222.432.4393.7076.700.6021.183.068,412,186.001.5510.132.5216.4753.4447.632.5812.830.58181.810.402313.00-16.5517.07-79.6811.3621.6821.67
J B Chemicals and Pharmaceuticals Ltd37.11bn6.11bn264.35bn5.31k44.278.2334.407.1238.4538.45233.33206.820.94812.594.856,987,882.0015.6115.7718.6218.8966.2661.1816.4716.062.2027.530.030333.0810.6316.2234.8423.3640.1537.42
Gland Pharma Ltd58.90bn6.92bn294.41bn4.22k42.573.3527.385.0041.9841.98357.57533.410.55671.284.1113,967,630.006.5413.237.6514.5660.3055.5811.7422.923.1433.110.03587.2656.2922.61-1.1011.3224.02--
Suven Pharmaceuticals Ltd9.61bn2.43bn324.43bn1.05k133.6416.40106.9333.759.549.5437.7377.710.41561.525.999,136,501.0010.5023.1711.5026.2061.4258.8525.2733.214.0029.500.019118.63-21.5622.71-26.9922.41-1.83--
Piramal Pharma Ltd87.04bn453.30m324.55bn6.72k721.714.1040.343.730.34070.340766.3659.910.57991.404.8812,954,040.000.302--0.428--63.69--0.5208--0.56037.490.3771--15.39--109.56------
Ajanta Pharma Ltd44.91bn8.75bn367.93bn7.84k42.3510.0136.368.1969.5569.55356.94294.360.97381.334.165,725,128.0018.9716.6123.2920.4775.7773.2219.4819.312.1349.880.008831.2012.4515.4138.8116.10-14.9710.76
Data as of Nov 22 2024. Currency figures normalised to Laurus Labs Ltd's reporting currency: Indian Rupee INR

Institutional shareholders

26.31%Per cent of shares held by top holders
HolderShares% Held
Capital Research & Management Co. (World Investors)as of 07 Nov 202459.18m10.98%
Mirae Asset Investment Managers (India) Pvt Ltd.as of 06 Aug 202415.88m2.95%
Life Insurance Corporation of India (Investment Portfolio)as of 30 Jun 202414.56m2.70%
The Vanguard Group, Inc.as of 06 Nov 202414.22m2.64%
SBI Funds Management Ltd.as of 31 Oct 202412.61m2.34%
Barclays Wealth Trustees (India) Pvt Ltd.as of 30 Jun 20246.50m1.21%
Dimensional Fund Advisors LPas of 07 Nov 20245.58m1.04%
BlackRock Fund Advisorsas of 07 Nov 20244.84m0.90%
DSP Asset Managers Pvt. Ltd.as of 31 Oct 20244.79m0.89%
Sundaram Asset Management Co. Ltd.as of 31 Oct 20243.71m0.69%
More ▼
Data from 30 Sep 2024 - 01 Nov 2024Source: FactSet Research Systems Inc.
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.